Effect of intraoperative infusion of dexmedetomidine on postoperative recovery in patients undergoing endovascular interventional therapies: A prospective, randomized, controlled trial

ConclusionsDexmedetomidine (an initial dose of 0.5 μg/kg for 10 min adjusted to 0.6 μg kg−1 hr−1 throughout EIT) could reduce the total consumption of nimodipine and opioid during the first 48 hr after surgery, the concerning adverse effects, and improve pain scores. The optimal dosage of dexmedetomidine during EITs merits further investigation.

Source: Brain and Behavior - May 16, 2019 Category: Neurology Authors: Chunguang Ren, Huiying Xu, Guangjun Xu, Lei Liu, Guoying Liu, Zongwang Zhang, Jun-Li Cao Tags: ORIGINAL RESEARCH Source Type: research